Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 160 articles:
HTML format
Text format



Single Articles


    September 2018
  1. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: a prospective Swedish population-based study.
    Thyroid. 2018 Sep 22. doi: 10.1089/thy.2018.0388.
    PubMed     Text format     Abstract available


  2. MAHAJAN P, Dawrant J, Kheradpour A, Quintanilla NM, et al
    Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0064.
    PubMed     Text format     Abstract available


  3. SONG YS, Won JK, Yoo SK, Jung KC, et al
    Comprehensive transcriptomic and genomic profiling of subtypes of follicular variant of papillary thyroid carcinoma.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0198.
    PubMed     Text format     Abstract available


    August 2018
  4. JAESCHKE H, Undeutsch H, Patyra K, Lof C, et al
    Hyperthyroidism and papillary thyroid carcinoma in thyrotropin receptor D633H mutant mice.
    Thyroid. 2018 Aug 22. doi: 10.1089/thy.2018.0041.
    PubMed     Text format     Abstract available


    July 2018
  5. DANIELS GH
    Follicular Thyroid Carcinoma: A Perspective.
    Thyroid. 2018 Jul 24. doi: 10.1089/thy.2018.0306.
    PubMed     Text format     Abstract available


  6. BOGDANOVA TI, Saenko VA, Brenner AV, Zurnadzhy LY, et al
    Comparative Histopathologic Analysis of "Radiogenic" and "Sporadic" Papillary Thyroid Carcinoma: Patients Born Before and After the Chernobyl Accident.
    Thyroid. 2018;28:880-890.
    PubMed     Text format     Abstract available


    June 2018
  7. MA B, Wei WJ, Xu W, Wang Y, et al
    Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: A retrospective case review and literature review.
    Thyroid. 2018 Jun 30. doi: 10.1089/thy.2017.0558.
    PubMed     Text format     Abstract available


  8. TRAN BM, Roshan DJ, Abraham E, Wang LY, et al
    The Prognostic Impact of Tumor Size in Papillary Thyroid Carcinoma is Modified by Age.
    Thyroid. 2018 Jun 19. doi: 10.1089/thy.2017.0607.
    PubMed     Text format     Abstract available


    May 2018
  9. HE H, Li W, Yan P, Bundschuh R, et al
    Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    Thyroid. 2018 May 16. doi: 10.1089/thy.2017.0258.
    PubMed     Text format     Abstract available


  10. CHU KP, Baker SP, Zenke JK, Morad A, et al
    Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2017.0136.
    PubMed     Text format     Abstract available


  11. CABANILLAS M, Ferrarotto R, Garden A, Ahmed S, et al
    Neoadjuvant BRAF- and immune- directed therapy for anaplastic thyroid carcinoma.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2018.0060.
    PubMed     Text format     Abstract available



  12. Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study, by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH, an
    Thyroid. 2018;28:686.
    PubMed     Text format    


    March 2018
  13. ROSARIO PW
    Re: "A Follow-Up Strategy for Patients with Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma" by Jeon et al. (Thyroid 2018;28:187-192).
    Thyroid. 2018 Mar 27. doi: 10.1089/thy.2017.0644.
    PubMed     Text format    


    February 2018
  14. LEI J, Zhong J, Li Z, Wei T, et al
    A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0422.
    PubMed     Text format     Abstract available


  15. KIM M, Jeon M, Oh HS, Park S, et al
    <i>BRAF</i> and <i>RAS</i> mutational status in non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0382.
    PubMed     Text format     Abstract available


  16. HIRSCH D, Twito O, Levy S, Bachar G, et al
    Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma - An Israeli Multicenter Study.
    Thyroid. 2018 Feb 5. doi: 10.1089/thy.2017.0371.
    PubMed     Text format     Abstract available


    January 2018
  17. LUBITZ CC, Zhan T, Gunda V, Amin S, et al
    Circulating BRAFV600E levels correlate with treatment in patients with thyroid carcinoma.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0322.
    PubMed     Text format     Abstract available


  18. JAHANBANI I, Al-Abdallah A, Ali R, Al-Brahim N, et al
    Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0127.
    PubMed     Text format     Abstract available


  19. KIM M, Kim TH, Shin DY, Lim DJ, et al
    Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0356.
    PubMed     Text format     Abstract available


  20. OH HS, Kwon H, Song E, Jeon M, et al
    Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0514.
    PubMed     Text format     Abstract available


  21. KIM MJ, Won JK, Jung KC, Kim JH, et al
    Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma.
    Thyroid. 2018 Jan 17. doi: 10.1089/thy.2016.0671.
    PubMed     Text format     Abstract available


  22. CARVALHO M, Rosario PW, Mourao GF, Oliveira LFF, et al
    Clinical impact of detectable antithyroglobulin antibodies below the reference limit (borderline) in patients with papillary thyroid carcinoma with negative serum thyroglobulin and neck ultrasonography after ablation: a prospective study.
    Thyroid. 2018 Jan 12. doi: 10.1089/thy.2017.0350.
    PubMed     Text format     Abstract available


    November 2017
  23. JEON M, Kim M, Park S, Oh HS, et al
    A follow-up strategy for patients with excellent response to initial therapy for differentiated thyroid carcinoma : less is better.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0130.
    PubMed     Text format     Abstract available


  24. WATUTANTRIGE-FERNANDO S, Vianello F, Barollo S, Bertazza L, et al
    The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0248.
    PubMed     Text format     Abstract available


  25. IYER P, Dadu R, Ferrarotto R, Busaidy N, et al
    Real world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma.
    Thyroid. 2017 Nov 22. doi: 10.1089/thy.2017.0285.
    PubMed     Text format     Abstract available


  26. KLEIN HESSELINK MS, Bocca G, Hummel YM, Brouwers AH, et al
    Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma.
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0383.
    PubMed     Text format     Abstract available


  27. GOMES-LIMA CJ, Wu D, Kharazi PH, Khorjekar G, et al
    Selected Radiation Safety Aspects including Transportation and Lodging after Outpatient <sup>131</sup>I Therapy for Differentiated Thyroid Cancer.
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0124.
    PubMed     Text format     Abstract available


  28. NAM SH, Roh JL, Gong G, Cho KJ, et al
    Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Thyroid. 2017 Nov 8. doi: 10.1089/thy.2017.0334.
    PubMed     Text format     Abstract available


  29. KUO EJ, Thi WJ, Zheng F, Zanocco K, et al
    Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension.
    Thyroid. 2017 Nov 7. doi: 10.1089/thy.2017.0457.
    PubMed     Text format     Abstract available


  30. HA SM, Ahn HS, Baek JH, Ahn HY, et al
    Validation of Three Scoring Risk Stratification Models for Thyroid Nodules.
    Thyroid. 2017 Nov 6. doi: 10.1089/thy.2017.0363.
    PubMed     Text format     Abstract available


  31. VALENCIAGA A, Grubbs EG, Porter K, Wakely PE Jr, et al
    REDUCED RETINOBLASTOMA PROTEIN EXPRESSION IS ASSOCIATED WITH DECREASED PATIENT SURVIVAL IN MEDULLARY THYROID CANCER.
    Thyroid. 2017 Nov 4. doi: 10.1089/thy.2017.0113.
    PubMed     Text format     Abstract available


  32. CIBAS ES, Ali SZ
    The 2017 Bethesda System for Reporting Thyroid Cytopathology.
    Thyroid. 2017;27:1341-1346.
    PubMed     Text format     Abstract available


    October 2017
  33. SCHMOHL KA, Dolp P, Schug C, Knoop K, et al
    Reintroducing the sodium iodide symporter (NIS) to anaplastic thyroid carcinoma.
    Thyroid. 2017 Oct 15. doi: 10.1089/thy.2017.0290.
    PubMed     Text format     Abstract available


  34. LAMARTINA L, Durante C, Lucisano G, Grani G, et al
    Are evidence-based guidelines reflected in clinical practice? An analysis of prospectively collected data of the Italian Thyroid Cancer Observatory (ITCO#1).
    Thyroid. 2017 Oct 12. doi: 10.1089/thy.2017.0299.
    PubMed     Text format     Abstract available


  35. HERNANDEZ-PRERA J, Machado R, Asa SL, Baloch ZW, et al
    Pathologic reporting of Tall Cell Variant of Papillary Thyroid Cancer: Have we reached a consensus?
    Thyroid. 2017 Oct 12. doi: 10.1089/thy.2017.0280.
    PubMed     Text format     Abstract available


  36. BARDET S, Ciappuccini R, Pellot-Barakat C, Monpeyssen H, et al
    Shear wave elastography in thyroid nodules with indeterminate cytology: Results of a prospective bicentric study.
    Thyroid. 2017 Oct 6. doi: 10.1089/thy.2017.0293.
    PubMed     Text format     Abstract available


  37. AYUBI E, Sullman MJM, Safiri S
    Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy: Comment on Data Sparsity.
    Thyroid. 2017 Oct 1. doi: 10.1089/thy.2017.0303.
    PubMed     Text format     Abstract available


    September 2017
  38. HA EJ, Baek JH, Na DG
    Risk Stratification of Thyroid Nodules on Ultrasonography: Current Status and Perspectives.
    Thyroid. 2017 Sep 25. doi: 10.1089/thy.2016.0654.
    PubMed     Text format     Abstract available


  39. CANO JM, Galan R, Lopez R
    Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
    Thyroid. 2017.
    PubMed     Text format     Abstract available


  40. LEE SI, Kim DK, Seo EJ, Choi EJ, et al
    Role of Kruppel-like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Thyroid. 2017.
    PubMed     Text format     Abstract available


  41. YAPA S, Mulla O, Green V, England J, et al
    The Role of Chemokines in Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2016.0660.
    PubMed     Text format     Abstract available


  42. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    <i>ESR2</i> gene and Medullary Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0171.
    PubMed     Text format     Abstract available


  43. PONTIUS LN, Oyekunle TO, Thomas S, Stang M, et al
    Projecting Survival in Papillary Thyroid Cancer: A Comparison of the 7th and 8th Editions of the AJCC/UICC Staging Systems in Two Contemporary National Patient Cohorts.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0306.
    PubMed     Text format     Abstract available


  44. HEDMAN C, Strang P, Djarv T, Widberg I, et al
    Anxiety and fear of recurrence despite a good prognosis: an interview study with differentiated thyroid cancer patients.
    Thyroid. 2017 Sep 6. doi: 10.1089/thy.2017.0346.
    PubMed     Text format     Abstract available


    August 2017
  45. SAHLI ZT, Umbricht CB, Schneider EB, Zeiger MA Md, et al
    Thyroid Nodule Diagnostic Markers in the Face of the New Diagnosis, NIFT-P: Time for a Reset?
    Thyroid. 2017 Aug 31. doi: 10.1089/thy.2017.0238.
    PubMed     Text format     Abstract available


  46. HALL S, Irish JC, Groome PA, Griffiths R, et al
    Do lower risk thyroid cancer patients who live in regions with more aggressive treatments have better outcomes?
    Thyroid. 2017 Aug 29. doi: 10.1089/thy.2017.0103.
    PubMed     Text format     Abstract available


  47. SUNG TY, Cho JW, Lee YM, Lee YH, et al
    Dynamic Risk Stratification in Stage I Papillary Thyroid Cancer Patients Younger than 45 Years.
    Thyroid. 2017 Aug 28. doi: 10.1089/thy.2017.0199.
    PubMed     Text format     Abstract available


  48. CHINN SB, Zafereo M, Waguespack SG, Edeiken BS, et al
    Long-term outcomes of lateral neck dissection in patients with recurrent or persistent well-differentiated thyroid cancer.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0203.
    PubMed     Text format     Abstract available


  49. VALDERRABANO P, Khazai L, Thompson ZJ, Leon ME, et al
    Cancer risk stratification of indeterminate thyroid nodules: A cytological approach.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0221.
    PubMed     Text format     Abstract available


  50. GRANI G, Bruno R, Lucisano G, Costante G, et al
    Temporal changes in thyroid nodule volume: lack of effect on paranodular thyroid tissue volume.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0201.
    PubMed     Text format     Abstract available


  51. WHITE PS, Pudusseri A, Lee SL, Eton O, et al
    Intermittent Dosing of Dabrafenib and Trametinib in Metastatic BRAFV600E Mutated Papillary Thyroid Cancer: Two Case Reports.
    Thyroid. 2017 Aug 12. doi: 10.1089/thy.2017.0106.
    PubMed     Text format     Abstract available


  52. RUHLMANN M, Ruhlmann J, Gorges R, Herrmann K, et al
    18F-FDG PET/CT may exclude malignancy in sonographically suspicious and scintigraphically hypofunctional thyroid nodules and reduce unnecessary thyroid surgeries.
    Thyroid. 2017 Aug 10. doi: 10.1089/thy.2017.0026.
    PubMed     Text format     Abstract available


  53. ROBENSHTOK E, Nachalon Y, Benbassat C, Hirsch D, et al
    Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0040.
    PubMed     Text format     Abstract available


  54. SUH CH, Choi YJ, Lee JJ, Shim WH, et al
    Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by 18F-FDG PET/CT: A Propensity Score Analysis.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0192.
    PubMed     Text format     Abstract available


  55. HA SM, Baek JH, Kim JK
    Detection of malignancy among suspicious thyroid nodules less than 1 cm on ultrasound with various thyroid image reporting and data systems.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0034.
    PubMed     Text format     Abstract available


    July 2017
  56. OH HS, Park S, Kim M, Kwon H, et al
    Young age and male sex can predict for a large-volume central neck lymph node metastasis in clinical N0 papillary thyroid microcarcinoma.
    Thyroid. 2017 Jul 25. doi: 10.1089/thy.2017.0250.
    PubMed     Text format     Abstract available


  57. ALHASHEMI A, Jones J, Goldstein DP, Santa Mina D, et al
    An Exploratory Study of Fatigue and Physical Activity in Canadian Thyroid Cancer Patients.
    Thyroid. 2017 Jul 16. doi: 10.1089/thy.2016.0541.
    PubMed     Text format     Abstract available


  58. HAHN SY, Shin JH, Oh YL, Kim TH, et al
    Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2016.0677.
    PubMed     Text format     Abstract available


  59. PARK S, Kim WG, Han M, Jeon M, et al
    Thyroid-Stimulating Hormone Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0177.
    PubMed     Text format     Abstract available


    June 2017
  60. KIYOTA N, Robinson B, Shah MH Md, Hoff AO, et al
    Defining Radioiodine-refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-refractory Criteria in the SELECT Trial.
    Thyroid. 2017 Jun 30. doi: 10.1089/thy.2016.0549.
    PubMed     Text format     Abstract available


  61. TANG AL, Falciglia M, Yang H, Mark JR, et al
    Validation of ATA Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine Needle Aspiration.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0555.
    PubMed     Text format     Abstract available


  62. KLUBO-GWIEZDZINSKA J, Yang LA, Merkel R, Patel D, et al
    Results of screening in familial nonmedullary thyroid cancer.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0668.
    PubMed     Text format     Abstract available


  63. ITO Y, Onoda N, Ito KI, Sugitani I, et al
    Sorafenib in Japanese Patients With Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2016.0621.
    PubMed     Text format     Abstract available


  64. KIM M, Kim WG, Oh HS, Park S, et al
    Comparison of the 7th and 8th Editions of the AJCC/UICC TNM Staging System for Differentiated Thyroid Cancer.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2017.0050.
    PubMed     Text format     Abstract available


  65. SILVA-VIEIRA M, Carrilho-Vaz S, Esteves S, C Ferreira T, et al
    Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Thyroid. 2017 Jun 14. doi: 10.1089/thy.2016.0655.
    PubMed     Text format     Abstract available


  66. PILLI T, Cantara S, Marzocchi C, Cardinale S, et al
    Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients.
    Thyroid. 2017 Jun 12. doi: 10.1089/thy.2017.0035.
    PubMed     Text format     Abstract available


    May 2017
  67. GONZALEZ HE, Martinez JR, Vargas S, Solar A, et al
    A 10-gene classifier for indeterminate thyroid nodules: Development and multicenter accuracy study.
    Thyroid. 2017 May 18. doi: 10.1089/thy.2017.0067.
    PubMed     Text format     Abstract available


  68. POLE JD, Zuk AM, Wasserman JD
    Diagnostic and Treatment Patterns among Children, Adolescents and Young Adults with Thyroid Cancer in Ontario: 1992-2010.
    Thyroid. 2017 May 17. doi: 10.1089/thy.2016.0629.
    PubMed     Text format     Abstract available


  69. RANDLE RW, Bushman NM, Orne J, Balentine CJ, et al
    PAPILLARY THYROID CANCER: THE GOOD AND BAD OF THE "GOOD CANCER".
    Thyroid. 2017 May 16. doi: 10.1089/thy.2016.0632.
    PubMed     Text format     Abstract available


  70. HAMAOKA Y
    Comment on "Comprehensive Survey Results of Childhood Thyroid Ultrasound Examinations in Fukushima in the First Four Years after the Fukushima Daiichi Nuclear Power Plant Accident".
    Thyroid. 2017 May 15. doi: 10.1089/thy.2016.0464.
    PubMed     Text format     Abstract available


  71. WILSON L, Huang W, Chen L, Ting J, et al
    Cost-Effectiveness of Lenvatinib, Sorafenib, and Placebo in the Treatment of Radioiodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2017 May 9. doi: 10.1089/thy.2016.0572.
    PubMed     Text format     Abstract available


  72. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    The effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma - a population-based study in Sweden.
    Thyroid. 2017 May 5. doi: 10.1089/thy.2016.0604.
    PubMed     Text format     Abstract available


  73. INIGUEZ ARIZA NM, Ryder M, Hilger CR, Bible KC, et al
    Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2016.0627.
    PubMed     Text format     Abstract available


  74. KIM M, Kim WG, Park S, Kwon H, et al
    Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma.
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0676.
    PubMed     Text format     Abstract available


  75. HONG MJ, Na DG, Baek JH, Sung JY, et al
    Cytology-Ultrasonography (CU) Risk Stratification Scoring System Based on Fine-needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System (K-TIRADS).
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0603.
    PubMed     Text format     Abstract available


  76. CHUNG SR, Baek JH, Park HS, Choi YJ, et al
    Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.
    Thyroid. 2017;27:707-713.
    PubMed     Text format     Abstract available


    April 2017
  77. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Text format     Abstract available


  78. OH HS, Kim WG, Park S, Kim M, et al
    Serial neck ultrasonographic evaluation of changes in papillary thyroid carcinoma during pregnancy.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0618.
    PubMed     Text format     Abstract available


  79. KIM H, Kim TH, Choe JH, Kim JH, et al
    Patterns of initial recurrence in completely resected papillary thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0648.
    PubMed     Text format     Abstract available


  80. YANG Z, Flores J, Katz S, Nathan CA, et al
    Comparison of survival outcomes following post-surgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0650.
    PubMed     Text format     Abstract available


  81. MA C, Feng F, Wang S, Fu H, et al
    Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant.
    Thyroid. 2017 Apr 12. doi: 10.1089/thy.2015.0658.
    PubMed     Text format     Abstract available


  82. PAULSON VA, Shivdasani P, Angell TE, Cibas ES, et al
    Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Thyroid. 2017;27:506-511.
    PubMed     Text format     Abstract available


  83. MUJAMMAMI M, Tamilia M
    Response to Tulchinsky and Avram re: "Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine".
    Thyroid. 2017;27:592.
    PubMed     Text format    


    March 2017
  84. IYAMA K, Matsuse M, Mitsutake N, Rogounovitch T, et al
    Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET in Thyroid Cancers of Young Patients in Fukushima.
    Thyroid. 2017 Mar 29. doi: 10.1089/thy.2016.0673.
    PubMed     Text format     Abstract available


  85. BONHOMME B, Godbert Y, Perot G, Alghuzlan A, et al
    Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0254.
    PubMed     Text format     Abstract available


  86. TAVARELLI M, Sarfati J, Chereau N, Tissier F, et al
    Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0512.
    PubMed     Text format     Abstract available


  87. IZKHAKOV E, Barchana M, Liphshiz I, Silverman B, et al
    Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
    Thyroid. 2017 Mar 24. doi: 10.1089/thy.2016.0481.
    PubMed     Text format     Abstract available


  88. LANG BH, Woo YC, Chiu KW
    Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules.
    Thyroid. 2017 Mar 22. doi: 10.1089/thy.2016.0664.
    PubMed     Text format     Abstract available


  89. NICKEL B, Brito JP, Barratt A, Jordan S, et al
    Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.
    Thyroid. 2017 Mar 21. doi: 10.1089/thy.2016.0483.
    PubMed     Text format     Abstract available


  90. SHAH SA, Adam MA, Thomas S, Scheri RP, et al
    Racial Disparities In Differentiated Thyroid Cancer: Have We Bridged The Gap?
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0626.
    PubMed     Text format     Abstract available


  91. ZANELLA AB, Scheffel RS, Pasa M, Dora JM, et al
    The Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
    Thyroid. 2017 Mar 14. doi: 10.1089/thy.2016.0559.
    PubMed     Text format     Abstract available


    February 2017
  92. MOON S, Song YS, Kim YA, Lim JA, et al
    Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2017 Feb 9. doi: 10.1089/thy.2016.0350.
    PubMed     Text format     Abstract available


    January 2017
  93. XU B, Tallini G, Scognamiglio T, Roman BR, et al
    Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Thyroid. 2017 Jan 30. doi: 10.1089/thy.2016.0649.
    PubMed     Text format     Abstract available


  94. MURATA T, Iwadate M, Takizawa Y, Miyakoshi M, et al
    An adult mouse thyroid side population cell line that exhibits enriched epithelial-to-mesenchymal transition.
    Thyroid. 2017 Jan 27. doi: 10.1089/thy.2016.0130.
    PubMed     Text format     Abstract available


  95. GRIFFIN A, Brito JP, Bahl M, Hoang JK, et al
    Applying criteria of active surveillance to low-risk thyroid papillary cancer over a decade: How many surgeries and complications can be avoided?
    Thyroid. 2017 Jan 26. doi: 10.1089/thy.2016.0568.
    PubMed     Text format     Abstract available


  96. HAUGEN BR MD, Sawka AM, Alexander EK, Bible KC, et al
    The ATA Guidelines on Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of eFVPTC without Invasion to NIFTP.
    Thyroid. 2017 Jan 23. doi: 10.1089/thy.2016.0628.
    PubMed     Text format     Abstract available


  97. CHOI YJ, Baek JH, Park HS, Shim WH, et al
    A computer-aided diagnosis system using artificial intelligence for the diagnosis and characterization of thyroid nodules on ultrasound: initial clinical assessment.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0372.
    PubMed     Text format     Abstract available


  98. ESZLINGER M, Bohme K, Ullmann M, Gorke F, et al
    Evaluation of a two-year routine application of molecular testing of thyroid fine needle aspirations (FNA) using a 7-gene-panel in a primary referral setting in Germany.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0445.
    PubMed     Text format     Abstract available


  99. ALEXANDER EK, Pearce EN, Brent GA, Brown RS, et al
    2016 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum.
    Thyroid. 2017 Jan 6. doi: 10.1089/thy.2016.0457.
    PubMed     Text format     Abstract available


  100. ITO M, Miyauchi A, Fujiwara M, Yoshioka W, et al
    Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy.
    Thyroid. 2017 Jan 5. doi: 10.1089/thy.2016.0426.
    PubMed     Text format     Abstract available


  101. CAVALLO A, Johnson DN, White MG, Siddiqui S, et al
    Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size.
    Thyroid. 2017 Jan 4. doi: 10.1089/thy.2016.0336.
    PubMed     Text format     Abstract available


  102. VAN DER WARDT RA, Persoon AC, Klein Hesselink EN, Links TP, et al
    Long-term follow-up for differentiated thyroid carcinoma patients - a reconsideration.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0314.
    PubMed     Text format     Abstract available


  103. AZMAT U, Porter K, Senter L, Ringel MD, et al
    Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.
    Thyroid. 2017;27:74-80.
    PubMed     Text format     Abstract available


    December 2016
  104. SHEN FC, Hsieh CJ, Huang IC, Chang YH, et al
    Dynamic risk estimates of outcome in Chinese patients with well-differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation.
    Thyroid. 2016 Dec 22. doi: 10.1089/thy.2016.0479.
    PubMed     Text format     Abstract available


  105. HAYMART MR, Pearce EN
    How Much Should Thyroid Cancer Impact Plans for Pregnancy?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    November 2016
  106. PARK S, Kim WG, Song E, Oh HS, et al
    Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated without Radioactive Iodine Remnant Ablation Therapy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  107. SHAHA MA, Wang LY, Migliacci JC, Palmer FL, et al
    Previous external beam radiation treatment exposure does not confer worse outcome for patients with differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  108. RAKHLIN L, Fish S, Tuttle RM Md
    Response to therapy status is an excellent predictor of pregnancy-associated structural disease progression in patients previously treated for differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  109. JI Q, Shi R, Qu N, Luo T, et al
    Programmed death-ligand 1 expression in papillary thyroid cancer and its correlation with clinicopathological factors and recurrence.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  110. ALZAHRANI AS, Murugan AK, Qasem E, Alswailem M, et al
    Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  111. RAGO T, Scutari M, Loiacono V, Santini F, et al
    Low elasticity of thyroid nodules at ultrasound elastography is correlated with malignancy, degree of fibrosis and high expression of galectin-3 and fibronectin-1.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    October 2016
  112. CASTELBLANCO E, Zafon C, Maravall J, Gallel P, et al
    APLP2, RRM2 and PRC1: new putative markers for the differential diagnosis of thyroid follicular lesions.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  113. RABINOWITS G, Barletta J, Sholl LM, Reche E, et al
    Successful Management of a Patient with Malignant Thyroid Teratoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  114. JEONG HS, Choi EK, Song IU, Chung YA, et al
    Differences in brain glucose metabolism during preparation for I-131 ablation in thyroid cancer patients: Thyroid hormone withdrawal versus recombinant human thyrotropin.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  115. MERTEN MM, Castro MR, Zhang J, Durski JM, et al
    Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography (PET/CT) in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  116. WANG Q, Yang H, Wu L, Yao J, et al
    Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathological Characteristics and BRAF-mutation in Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  117. BHALLA S, Monga D, Soni T, Gaurang A, et al
    Competency Education of Primary Care Physicians in Management of Thyroid Disorders: Implementation Experiences from a Pan India Certificate Course.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  118. ROSSING RM, Jentzen W, Nagarajah J, Bockisch A, et al
    Serum thyroglobulin doubling time in progressive thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  119. LEE SG, Lee WK, Lee HS, Moon J, et al
    Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  120. GAVRILA A, Hasselgren PO, Glasgow A, Doyle AN, et al
    Variable Cold-induced Brown Adipose Tissue Response to Thyroid Hormone Status.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  121. NAJAFIAN A, Noureldine SI, Azar F, Atallah C, et al
    RAS Mutations, RET/PTC and PAX8/PPAR-gamma Chromosomal Rearrangements Are Also Prevalent in Benign Thyroid Lesions? Implications Thereof and, A Systematic Review.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  122. TULCHINSKY M, Avram A
    Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine: Patient Cohort Definition Makes No Sense.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    September 2016
  123. AHN HS, Kim HJ, Kim KH, Lee YS, et al
    Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  124. REN Y, Lence-Anta JJ, Pereda C, Chappa M, et al
    Foxe1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  125. SINGER S, Husson O, Tomaszewska IM, Locati L, et al
    Quality of life priorities in patients with thyroid cancer - a multi-national EORTC phase I study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  126. YOUNGWIRTH L, Abdelgadir Adam M, Scheri R, Roman S, et al
    Extrathyroidal Extension is Associated with Compromised Survival in Patients with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  127. WILTSHIRE JJ, Drake TM, Uttley L, Balasubramanian SP, et al
    Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  128. IPPOLITO S, Ippolito R, Peirce C, Esposito R, et al
    Recombinant Human Thyroid Stimulating Hormone Improves Endothelial Coronary Flow Reserve in Thyroidectomized Patients With Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  129. ESPINOSA DE YCAZA AE, Lowe KM, Dean DS, Castro MR, et al
    Risk of Malignancy in Thyroid Nodules with Non-diagnostic Fine Needle Aspiration: A Retrospective Cohort Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  130. PIRES B, Alves-Junior PA, Bordallo MA, Bulzico DA, et al
    Prognostic factors for early and long-term remission in pediatric differentiated thyroid cancer: the role of gender, age, clinical presentation and the newly proposed American Thyroid Association risk stratification system.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  131. ONODA N, Sugino K, Higashiyama T, Kammori M, et al
    The safety and efficacy of weekly paclitaxel administration for anaplastic thyroid cancer patients: A nationwide prospective study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  132. NIXON IJ, Simo R, Newbold K, Rinaldo A, et al
    Management of Invasive Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  133. CUI K, Zhang M, Fu C, Ma X, et al
    Comment on "Partially Cystic Thyroid Nodules on Ultrasound: Probability of Malignancy and Sonographic Differentiation".
    Thyroid. 2016.
    PubMed     Text format    


  134. STRICKLAND KC, Vivero M, Jo VY, Lowe AC, et al
    Pre-operative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): A Prospective Analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  135. ZHANG M, Luo Y, Zhang Y, Tang J, et al
    Efficacy and safety of ultrasound guided radiofrequency ablation for treating low risk papillary thyroid microcarcinoma: a prospective study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  136. RATZON NZ, Uziely B, de Boer AG, Rottenberg Y, et al
    Unemployment risk and decreased income 2 and 4 years after thyroid cancer diagnosis: a population based study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    June 2016
  137. HYUN YG, Alhashemi A, Fazelzad R, Goldberg AS, et al
    A Systematic Review of Unmet Information and Psychosocial Support Needs of Adults Diagnosed with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  138. MALANDRINO P, Russo M, Regalbuto C, Pellegriti G, et al
    The Outcome Of The Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  139. BERNSTEIN MB, Chang EL, Amini B, Pan H, et al
    SPINE STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH METASTATIC THYROID CANCER - Secondary analysis of Phase I/II trials.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  140. VALDERRABANO P, Montilla Soler J, Mifsud MJ, Leon ME, et al
    Hypermetabolism on 18F-FDG PET scan does not influence the interpretation of thyroid cytopathology and nodules with SUVmax <2.5 are not at increased risk for malignancy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  141. BRITO JP, Bleyer A
    Impact of thyroid cancer on the incidence and survival of adolescents and young adults with cancer.
    Thyroid. 2016.
    PubMed     Text format    


  142. HIRSCH D, Shohat T, Gorshtein A, Robenshtok E, et al
    Incidence of Non-thyroidal Primary Malignancy and the Association with I-131 Treatment in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  143. GULEC SA, Kuker RA
    The Clinical Value of I-124 PET/CT Imaging in Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format    


  144. SHRESTHA RT, Evasovich MR, Amin K, Radulescu A, et al
    Correlation between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules - A Two Year Institutional Experience.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  145. WHITE MG, Cipriani NA, Abdulrasool L, Kaplan SP, et al
    Radiation Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease Free Survival.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  146. JINDAL A, Khan U
    Is Thyroglobulin level by LC-MS/MS always reliable for follow-up of DTC after Thyroidectomy: A report of 2 cases.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  147. PANI F, Atzori F, Baghino G, Boi F, et al
    HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  148. ANDERSON K, Youngwirth L, Scheri R, Stang M, et al
    T1a vs T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  149. CAMPENNI A, Giovanella L, Siracusa M, Alibrandi A, et al
    99mTc-METHOXY-ISOBUTYL-ISONITRILE (MIBI) SCINTIGRAPHY IS A USEFUL TOOL FOR ASSESSING THE RISK OF MALIGNANCY IN THYROID NODULES WITH INDETERMINATE FINE NEEDLE CYTOLOGY (FNAC).
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  150. SHARMA A, Jasim S, Reading CC, Ristow K, et al
    Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma - A Cohort Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  151. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    The G534E variant in <i>HABP2</i> and Nonmedullary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    May 2016
  152. KIST JW, de Keizer B, Vogel WV
    Letter to the Editor regarding the article "I-124 PET/CT in patients with differentiated thyroid cancer: clinical and quantitative image analysis".
    Thyroid. 2016.
    PubMed     Text format    


  153. HODAK S, Tuttle RM Md, Maytal G, Nikiforov YE, et al
    Changing the Cancer Diagnosis - the Case of Follicular Variant of Papillary Thyroid Cancer Primum, Non Nocere and NIFTP.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  154. WU JX, Young S, Hung M, Li N, et al
    Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  155. GOLDFARB M, Casillas J
    Thyroid Cancer Specific Quality of Life and Health Related Quality of Life in Young Adult Thyroid Cancer Survivors.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  156. MUJAMMAMI MH, Hier MP, Payne RJ, Rochon L, et al
    Long-term Outcomes of Patients with Papillary Thyroid Cancer undergoing Remnant Ablation with 30 milliCuries Radioiodine.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    April 2016
  157. CAZARIN JM, Coelho RG, Hecht F, Andrade BM, et al
    5 -AMP-activated Protein Kinase (AMPK) Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion and Epithelial-to-Mesenchymal Transition.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  158. LA COUR JL, Andersen UB, Sorensen CH, Nygaard B, et al
    Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid Arteries.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  159. HAKALA TT, Kholova I
    Changes in classification of follicular thyroid cancers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    March 2016
  160. BRITO JP, Kim HJ, Han SJ, Lee YS, et al
    Geographic distribution and evolution of thyroid cancer epidemic in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: